Concepts (180)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arthroplasty, Replacement, Knee | 31 | 2021 | 561 | 3.290 |
Why?
|
| Arthroplasty, Replacement, Hip | 25 | 2016 | 696 | 1.820 |
Why?
|
| Knee Joint | 12 | 2016 | 577 | 1.220 |
Why?
|
| Knee Prosthesis | 13 | 2021 | 200 | 1.090 |
Why?
|
| Reoperation | 29 | 2021 | 767 | 0.910 |
Why?
|
| Minimally Invasive Surgical Procedures | 7 | 2007 | 295 | 0.730 |
Why?
|
| Prosthesis Failure | 18 | 2021 | 418 | 0.680 |
Why?
|
| Tendons | 3 | 2006 | 183 | 0.600 |
Why?
|
| Osteoarthritis, Knee | 5 | 2017 | 299 | 0.590 |
Why?
|
| Prosthesis Design | 17 | 2021 | 386 | 0.560 |
Why?
|
| Femur | 9 | 2010 | 311 | 0.560 |
Why?
|
| Humans | 62 | 2021 | 23495 | 0.550 |
Why?
|
| Patella | 6 | 2006 | 54 | 0.550 |
Why?
|
| Postoperative Complications | 12 | 2021 | 827 | 0.470 |
Why?
|
| Acetabulum | 9 | 2009 | 190 | 0.450 |
Why?
|
| Range of Motion, Articular | 11 | 2016 | 604 | 0.450 |
Why?
|
| Ambulatory Surgical Procedures | 2 | 2006 | 66 | 0.440 |
Why?
|
| Treatment Outcome | 20 | 2016 | 3058 | 0.430 |
Why?
|
| Tibia | 5 | 2019 | 197 | 0.420 |
Why?
|
| Pain, Postoperative | 3 | 2006 | 283 | 0.400 |
Why?
|
| Hemiarthroplasty | 1 | 2014 | 31 | 0.400 |
Why?
|
| Orthopedic Procedures | 4 | 2016 | 239 | 0.390 |
Why?
|
| Hip Prosthesis | 9 | 2016 | 436 | 0.360 |
Why?
|
| Aged | 27 | 2021 | 7709 | 0.360 |
Why?
|
| Middle Aged | 28 | 2021 | 8096 | 0.350 |
Why?
|
| Joint Diseases | 3 | 2016 | 95 | 0.340 |
Why?
|
| Sound Spectrography | 1 | 2010 | 14 | 0.330 |
Why?
|
| Hip Fractures | 1 | 2010 | 23 | 0.320 |
Why?
|
| Follow-Up Studies | 17 | 2021 | 1492 | 0.310 |
Why?
|
| Male | 30 | 2021 | 12823 | 0.310 |
Why?
|
| Female | 30 | 2021 | 13305 | 0.300 |
Why?
|
| Blood Loss, Surgical | 2 | 2007 | 53 | 0.300 |
Why?
|
| Radiography | 13 | 2016 | 547 | 0.300 |
Why?
|
| Recovery of Function | 8 | 2016 | 254 | 0.300 |
Why?
|
| Perioperative Care | 2 | 2006 | 42 | 0.280 |
Why?
|
| Clinical Competence | 2 | 2007 | 191 | 0.270 |
Why?
|
| Cementation | 6 | 2021 | 30 | 0.260 |
Why?
|
| Electrocoagulation | 1 | 2007 | 8 | 0.260 |
Why?
|
| Hemostasis, Surgical | 1 | 2007 | 12 | 0.260 |
Why?
|
| Tendon Injuries | 2 | 2005 | 163 | 0.240 |
Why?
|
| Polyethylenes | 1 | 2006 | 32 | 0.240 |
Why?
|
| Bone Transplantation | 2 | 2006 | 156 | 0.240 |
Why?
|
| Critical Pathways | 1 | 2006 | 19 | 0.240 |
Why?
|
| Femoral Fractures | 1 | 2006 | 32 | 0.240 |
Why?
|
| Osteolysis | 4 | 2010 | 114 | 0.230 |
Why?
|
| Hip Joint | 5 | 2016 | 387 | 0.220 |
Why?
|
| Decision Support Techniques | 1 | 2005 | 40 | 0.220 |
Why?
|
| Arthroscopy | 2 | 2016 | 742 | 0.210 |
Why?
|
| Time Factors | 9 | 2011 | 1276 | 0.210 |
Why?
|
| Lactones | 1 | 2003 | 9 | 0.200 |
Why?
|
| Arthroplasty | 1 | 2004 | 117 | 0.200 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2003 | 25 | 0.200 |
Why?
|
| Isoenzymes | 1 | 2003 | 51 | 0.200 |
Why?
|
| Adult | 18 | 2019 | 7090 | 0.200 |
Why?
|
| Prospective Studies | 6 | 2009 | 1528 | 0.180 |
Why?
|
| Ossification, Heterotopic | 2 | 2016 | 32 | 0.170 |
Why?
|
| Osteoarthritis, Hip | 2 | 2016 | 88 | 0.160 |
Why?
|
| Transplantation, Homologous | 3 | 2005 | 198 | 0.160 |
Why?
|
| Retrospective Studies | 10 | 2019 | 3082 | 0.150 |
Why?
|
| Biomechanical Phenomena | 4 | 2017 | 555 | 0.150 |
Why?
|
| Patient Selection | 2 | 2014 | 171 | 0.140 |
Why?
|
| Aged, 80 and over | 11 | 2010 | 3874 | 0.130 |
Why?
|
| Knee | 1 | 2017 | 38 | 0.130 |
Why?
|
| Pain Measurement | 4 | 2016 | 428 | 0.130 |
Why?
|
| Radiotherapy | 1 | 2016 | 31 | 0.120 |
Why?
|
| Joint Instability | 3 | 2016 | 325 | 0.120 |
Why?
|
| Medial Collateral Ligament, Knee | 1 | 2016 | 5 | 0.120 |
Why?
|
| Leg Length Inequality | 1 | 2016 | 9 | 0.120 |
Why?
|
| Braces | 1 | 2016 | 20 | 0.120 |
Why?
|
| Intraoperative Complications | 1 | 2016 | 59 | 0.110 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 2 | 2006 | 22 | 0.110 |
Why?
|
| Knee Injuries | 1 | 2016 | 127 | 0.110 |
Why?
|
| Analgesia, Patient-Controlled | 2 | 2006 | 20 | 0.110 |
Why?
|
| Hip Dislocation | 1 | 2016 | 59 | 0.110 |
Why?
|
| Analgesia, Epidural | 2 | 2006 | 54 | 0.110 |
Why?
|
| Surgery, Computer-Assisted | 2 | 2016 | 48 | 0.110 |
Why?
|
| Gait | 1 | 2017 | 386 | 0.100 |
Why?
|
| Bone Cements | 4 | 2009 | 78 | 0.100 |
Why?
|
| Posterior Cruciate Ligament | 2 | 2011 | 19 | 0.100 |
Why?
|
| Risk Assessment | 4 | 2016 | 552 | 0.100 |
Why?
|
| Education, Medical, Graduate | 1 | 2014 | 67 | 0.100 |
Why?
|
| Orthopedics | 2 | 2005 | 83 | 0.090 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2019 | 168 | 0.090 |
Why?
|
| Osteotomy | 2 | 2003 | 128 | 0.090 |
Why?
|
| Device Removal | 3 | 2009 | 68 | 0.090 |
Why?
|
| Cohort Studies | 4 | 2016 | 1500 | 0.090 |
Why?
|
| Internship and Residency | 1 | 2014 | 197 | 0.080 |
Why?
|
| Micro-Electrical-Mechanical Systems | 1 | 2010 | 1 | 0.080 |
Why?
|
| Vibration | 1 | 2010 | 27 | 0.080 |
Why?
|
| Double-Blind Method | 2 | 2016 | 374 | 0.080 |
Why?
|
| Health Status Indicators | 2 | 2010 | 66 | 0.070 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2011 | 252 | 0.070 |
Why?
|
| Severity of Illness Index | 3 | 2011 | 807 | 0.070 |
Why?
|
| Probability | 2 | 2004 | 74 | 0.070 |
Why?
|
| Marketing of Health Services | 1 | 2007 | 2 | 0.070 |
Why?
|
| Sodium Chloride | 1 | 2007 | 31 | 0.060 |
Why?
|
| Equipment Design | 1 | 2007 | 128 | 0.060 |
Why?
|
| Postoperative Period | 2 | 2019 | 265 | 0.060 |
Why?
|
| Bone Diseases | 1 | 2006 | 20 | 0.060 |
Why?
|
| Surface Properties | 1 | 2006 | 104 | 0.060 |
Why?
|
| Education, Medical, Continuing | 1 | 2006 | 29 | 0.060 |
Why?
|
| Clinical Protocols | 1 | 2006 | 53 | 0.060 |
Why?
|
| Supine Position | 1 | 2006 | 17 | 0.060 |
Why?
|
| Demography | 1 | 2006 | 60 | 0.060 |
Why?
|
| Metals | 1 | 2006 | 96 | 0.060 |
Why?
|
| Feasibility Studies | 1 | 2006 | 210 | 0.060 |
Why?
|
| Nerve Block | 1 | 2006 | 62 | 0.060 |
Why?
|
| Medical Laboratory Science | 1 | 2005 | 8 | 0.060 |
Why?
|
| Diffusion of Innovation | 1 | 2005 | 19 | 0.060 |
Why?
|
| Decision Trees | 1 | 2005 | 13 | 0.060 |
Why?
|
| Markov Chains | 1 | 2005 | 30 | 0.060 |
Why?
|
| Early Ambulation | 1 | 2004 | 14 | 0.050 |
Why?
|
| Rupture | 1 | 2004 | 86 | 0.050 |
Why?
|
| Physical Therapy Modalities | 1 | 2004 | 61 | 0.050 |
Why?
|
| Arthroplasty, Replacement | 1 | 2006 | 130 | 0.050 |
Why?
|
| Weight-Bearing | 1 | 2004 | 138 | 0.050 |
Why?
|
| Disease Progression | 3 | 2016 | 550 | 0.050 |
Why?
|
| Dyssomnias | 1 | 2003 | 5 | 0.050 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2003 | 23 | 0.050 |
Why?
|
| Cyclooxygenase 2 | 1 | 2003 | 29 | 0.050 |
Why?
|
| Postoperative Nausea and Vomiting | 1 | 2003 | 15 | 0.050 |
Why?
|
| Sulfones | 1 | 2003 | 20 | 0.050 |
Why?
|
| Sex Factors | 1 | 2004 | 403 | 0.050 |
Why?
|
| Osseointegration | 1 | 2003 | 69 | 0.050 |
Why?
|
| Inhalation | 1 | 2003 | 6 | 0.050 |
Why?
|
| Tibial Fractures | 1 | 2003 | 7 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2003 | 140 | 0.050 |
Why?
|
| Age Factors | 1 | 2004 | 656 | 0.050 |
Why?
|
| Musculoskeletal Diseases | 1 | 2003 | 32 | 0.050 |
Why?
|
| Preoperative Care | 2 | 2016 | 109 | 0.040 |
Why?
|
| Length of Stay | 1 | 2003 | 298 | 0.040 |
Why?
|
| Radiotherapy Dosage | 2 | 2016 | 92 | 0.040 |
Why?
|
| Analgesics, Opioid | 1 | 2003 | 215 | 0.040 |
Why?
|
| Patient Satisfaction | 1 | 2003 | 269 | 0.040 |
Why?
|
| Quality of Life | 1 | 2005 | 570 | 0.040 |
Why?
|
| Risk | 1 | 2019 | 166 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2019 | 232 | 0.040 |
Why?
|
| Polyethylene | 1 | 2019 | 95 | 0.040 |
Why?
|
| Equipment Failure Analysis | 2 | 2010 | 81 | 0.030 |
Why?
|
| Coated Materials, Biocompatible | 2 | 2010 | 40 | 0.030 |
Why?
|
| Spondylitis, Ankylosing | 1 | 2016 | 20 | 0.030 |
Why?
|
| Physical Examination | 1 | 2016 | 94 | 0.030 |
Why?
|
| Risk Adjustment | 1 | 2016 | 9 | 0.030 |
Why?
|
| Prosthesis Fitting | 1 | 2016 | 17 | 0.030 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2019 | 369 | 0.030 |
Why?
|
| Intraoperative Care | 1 | 2016 | 39 | 0.030 |
Why?
|
| Postoperative Care | 1 | 2016 | 113 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2017 | 351 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2005 | 227 | 0.030 |
Why?
|
| Health Care Costs | 2 | 2004 | 62 | 0.020 |
Why?
|
| Osteoarthritis | 1 | 2016 | 294 | 0.020 |
Why?
|
| Risk Factors | 2 | 2010 | 2026 | 0.020 |
Why?
|
| Polymethacrylic Acids | 1 | 2010 | 4 | 0.020 |
Why?
|
| United States | 2 | 2006 | 1814 | 0.020 |
Why?
|
| Illinois | 1 | 2010 | 225 | 0.020 |
Why?
|
| Patellofemoral Joint | 1 | 2010 | 47 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2009 | 217 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2007 | 58 | 0.020 |
Why?
|
| Blood Sedimentation | 1 | 2007 | 49 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2007 | 93 | 0.020 |
Why?
|
| Synovial Fluid | 1 | 2007 | 82 | 0.020 |
Why?
|
| Prosthesis-Related Infections | 1 | 2009 | 177 | 0.020 |
Why?
|
| Pelvic Bones | 1 | 2006 | 16 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2007 | 449 | 0.010 |
Why?
|
| Orthopedic Equipment | 1 | 2005 | 2 | 0.010 |
Why?
|
| Technology Assessment, Biomedical | 1 | 2005 | 3 | 0.010 |
Why?
|
| United States Food and Drug Administration | 1 | 2005 | 18 | 0.010 |
Why?
|
| Porosity | 1 | 2004 | 54 | 0.010 |
Why?
|
| Contraindications | 1 | 2004 | 26 | 0.010 |
Why?
|
| Sampling Studies | 1 | 2003 | 24 | 0.010 |
Why?
|
| Incidence | 1 | 2006 | 642 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2004 | 109 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2003 | 106 | 0.010 |
Why?
|
| Bone Wires | 1 | 2003 | 8 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2003 | 126 | 0.010 |
Why?
|
| Intraoperative Period | 1 | 2003 | 22 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2003 | 295 | 0.010 |
Why?
|
| Surgical Flaps | 1 | 2003 | 50 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2003 | 369 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2006 | 907 | 0.010 |
Why?
|